Benzinga | Mar 25, 2021 04:10PM EDT

Relay Therapeutics Q4 2020 Net Income $35.3M; Reports FY 2020 Net Loss $52.4M

Net Income/Loss: Net income was $35.3 million for the fourth quarter of 2020, as compared to a net loss of $23.9 million for the fourth quarter of 2019. Net loss was $52.4 million for the full year 2020, or a net loss per share of $5.40, as compared to a net loss of $75.3 million for the full year 2019, or a net loss per share of $21.82.